TIFFANY HOLLEY: Open Payments
NPI 1962811679 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,057 in 276 payments from 19 companies in 2025. Trend: 2023 $6,043 · 2024 $4,733 · 2025 $6,057
Food & beverage: $5,952Education: $105
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 44 | $959 |
| ABBVIE INC. | 44 | $731 |
| Janssen Biotech, Inc. | 30 | $605 |
| Regeneron Healthcare Solutions, Inc. | 15 | $517 |
| GENZYME CORPORATION | 13 | $384 |
| Incyte Corporation | 10 | $380 |
| Novartis Pharmaceuticals Corporation | 15 | $362 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $358 |
| Organon LLC | 12 | $333 |
| Amgen Inc. | 11 | $286 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, OPZELURA, ILUMYA, OTEZLA, RINVOQ.
Industry payments across WI — which companies pay providers there.
